Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide

Eur J Pediatr. 2000 Jul;159(7):550. doi: 10.1007/s004310051335.

Abstract

We report the case of a newborn infant affected by congenital hyperinsulinism who developed cholelithiasis associated with cholestatic jaundice following treatment with octreotide, a somatostatin analogue.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cholelithiasis / chemically induced*
  • Cholelithiasis / diagnostic imaging
  • Female
  • Humans
  • Hypoglycemia / drug therapy*
  • Infant, Newborn
  • Infant, Premature, Diseases / drug therapy*
  • Octreotide / administration & dosage
  • Octreotide / adverse effects*
  • Ultrasonography

Substances

  • Octreotide